piperazine citrate hydrate
Modify Date: 2024-01-07 10:14:52
piperazine citrate hydrate structure
|
Common Name | piperazine citrate hydrate | ||
|---|---|---|---|---|
| CAS Number | 41372-10-5 | Molecular Weight | 660.669 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H56N6O19 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol |
GHS07 |
Signal Word | Warning | |
| Name | Tripiperazine bis(2-hydroxypropane-1,2,3-tricarboxylate) pentahydrate |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C24H56N6O19 |
|---|---|
| Molecular Weight | 660.669 |
| Exact Mass | 660.317749 |
| PSA | 382.59000 |
| Storage condition | 2-8°C |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn,Xi |
| Risk Phrases | 65-36/37/38 |
| Safety Phrases | 23-24-62-26 |
| RIDADR | NONH for all modes of transport |
|
Endogenous formation of N-nitrosamines from piperazine and their urinary excretion following antihelmintic treatment with piperazine citrate.
Carcinogenesis 12(9) , 1595-9, (1991) Antihelmintic treatment with piperazine (1,4-diazacyclohexane) for microfilarie parasitism results in the endogenous formation of piperazine-derived N-nitrosamines. The urinary excretion of these N-ni... |
|
|
Some effects of piperazine citrate on skeletal muscle and central nervous system.
Arch. Int. Pharmacodyn. Ther. 290(1) , 104-16, (1987) In the frog rectus abdominis and rat phrenic nerve-diaphragm preparations, piperazine citrate was shown to have some neuromuscular blocking activity. In the rat, d-tubocurarine was 500 times more pote... |
|
|
Treatment of helminthic diseases.
Am. Fam. Physician 32(3) , 182-8, (1985)
|
| Citric acid sesquipiperazine salt hydrate,tri-Piperazine dicitrate |
| PIPERAZINE CITRATE HYDRATE |
| Piperazine citrate |
| Piperazine, 2-hydroxy-1,2,3-propanetricarboxylate, hydrate (3:2:1) (salt) |
| Piperazine 2-hydroxy-1,2,3-propanetricarboxylate hydrate (3:2:1) |